The mechanism of a family of proteins - cation diffusion facilitators (CDFs) - regulating an important cellular cycle of cell's energy conversion to necessary functions, has been discovered by Case Western Reserve University scientists. The finding has the potential to inform future research aimed at identifying ways to ensure the process works as designed and, if successful, could lead to significant breakthroughs in the treatment of Parkinson's, chronic liver disease and heart disease.
The results of this research were posted online June 22 by the journal Nature and will be published in the print edition at a later date.
"CDF is a major protein family type found in all forms of life," said senior author Mark R. Chance, PhD, the Charles W. and Iona A. Mathias Professor of Cancer Research, Case Western Reserve University School of Medicine. "Mutations or altered regulation of human CDFs modify the concentrations of metal ions critical to cell function and are associated with key human diseases, including those affecting endocrine, neurologic, hepatic and cardiovascular systems."
Chance and his colleagues studied a form of CDF found in bacteria where the protein YiiP functions like a motor, using energy in the form of a gradient of protons (hydrogen atoms) to pump zinc ions out of cells.
While zinc is pushed successfully out of the cell, a flow of protons is pulled into it. A perfectly functioning zinc-proton flow cycle, then, brings in protons, which the YiiP protein converts into conformational changes in the protein structure. Those changes, in turn, send zinc out of the cell. If the CDF-regulated gate controlling the zinc-proton cycle malfunctions, a range of diseases can result.
To visualize the zinc-proton cycle, Case Western Reserve scientists used sophisticated dynamic imaging technology the cellular cycle operates on time scales comparable to the blink of the eye. Dynamic imaging involved a labeling system x-ray-mediated hydroxyl radical footprinting that recognizes water molecules in transmembrane proteins. The scientists also used mass spectrometry, a powerful atom-and-molecule recognition technology, to study the labeled proteins. These technologies allowed investigators to watch the YiiP protein in real time as it took up zinc atoms and rearranged its structure cycle through a pumping sequence.
"Membrane proteins (including CDF) are some of the most important cellular drug targets, including G-protein coupled receptors (GPCR), which represent 50 percent of the non-antibiotic drug market." Chance said.
GPCRs are protein molecules that sense chemical signals outside the cell and then activate cellular responses to these signals. Chance and his colleagues have studied GPCR structure and dynamics using innovative mass spectrometry-based technology. In this more recent work on CDFs, a dynamic picture of the membrane protein has emerged. It is a complex, but explainable, machine that uses a widely available form of energy, the proton gradient, to carry out cellular functions.
"We have now produced high-resolution pictures of signal transmission and ion transport mechanisms for a range of ion channels and GPCRs," Chance said. "Our work in CDFs is a visible example of the power of these new technologies to solve important problems in the membrane protein field. We must continue to examine CDFs to understand their mechanisms of action, especially in the context of drug effects on the biochemical mechanisms of action."